Associate Director Government Pricing

Associate Director, Government Pricing (Open) – Reporting to the Director of Government Contracts and Pricing in Malvern, PA with additional locations in Bridgewater, NJ and Hazelwood, MO.

• Assist with oversight of calculation, review, audit, and submission of federal pricing values including AMP, BP, ASP, NFAMP, 340B PHS Ceiling Price, FCP, URA, Medicare PartB Inflationary Rebates and Medicare PartD Inflationary Rebates.
• Assist with identification and tracking of bona fide service fees per CMS qualitative and quantitative Fair Market Value assessments and obtain and submit customer bona fide service fee certifications.
• Provide review and approval for quarterly Medicaid and Medicare rebates.
• Assist with resolution of complex pricing issues, data anomalies, restatement decisions, and methodology assessments.
• Provide leadership support for Federal Supply Schedule contract renewals and annual Public Law processes.
• Ensure alignment and accuracy of government pricing data used in Gross-to-Net forecasting and accruals.
• Partner with Commercial Finance to maintain a comprehensive financial forecast model incorporating the latest government pricing and rebate assumptions.
• Assist with annual review and updates of Government Pricing policies, reasonable assumptions, SOPs and calculation methodologies (approximately 30 documents, 500+ pages).
• Assist with oversight of proper system configuration, master data accuracy, and adherence to approved methodologies and internal controls.
• Continue to strengthen internal controls, documentation standards, and compliance frameworks related to government pricing processes.
• Coordinate with IT and ModelN support teams to address system issues, manage updates, and maintain data integrity.
• Approve and oversee testing, validation, and governance for system integrations, upgrades, enhancements or regulatory changes impacting government pricing calculations.

• Provide leadership oversight and subject matter support for state drug price transparency submissions including price increases, new drug reporting, and cost/WAC changes.
• Support interpretation of emerging state legislation and oversee operational implementation.

• Partner with Legal, Government Affairs, and Compliance to monitor regulatory changes and assess their operational impact.
• Work routinely with Market Access, GTN Payments Team and third‑party vendors to analyze and optimize the 340B/Medicaid duplicate discount review and recovery process.
• Lead cross‑functional discussions on the government pricing implications of contract strategy, pricing actions, and commercial decision making.
• Provide training, education, and subject matter expertise to internal stakeholders.
• Represent the Government Pricing function in audit discussions, compliance reviews, and strategic initiatives.
• Maintain and enhance SOPs, policies, process flows, and governance documentation across all government price reporting.

• Bachelor’s degree required (Accounting, Finance, Business, Economics); an advanced degree, MBA or CPA preferred.
• 8+ years of progressive experience in pharmaceutical Government Pricing, Medicaid/Medicare reimbursement, pricing policy, or regulatory compliance.
• Prior leadership or team management experience strongly preferred.
• Deep technical expertise in AMP, BP, ASP, URA, 340B, and FSS/VA pricing required.
• Strong working knowledge of state drug price transparency requirements preferred.
• Experience with ModelN or similar GP system strongly preferred.
• Strong analytical, quantitative, and decision‑making skills with the ability to interpret complex regulations.
• Excellent communication, cross‑functional collaboration, and presentation skills.
• Ability to manage multiple priorities in a fast‑paced, compliance‑driven environment.
• High ethical standards and strong commitment to accuracy and compliant reporting practices.

This position reports to the Director, Government Contracts and Pricing and works closely with Finance, Gross-to-Net Accounting, Internal Audit, Market Access, Internal…